• The Horizons - Anne Arundel County, Pasadena
• Mercy Medical Center - Baltimore City

• Acute Pain Services (Bunionectomy correction, hammertoe correction and other surgical procedures of the foot and ankle).
• Chronic Pain Services (Neuropathic and OA pain)
• Skin and Skin Structure Infections (Fungal and bacterial infections, wound healing, Diabetic ulcers)
• Device trials- Prosthetic and implantable devices

* Principal Investigator

ABBO2814 M03-609 (Nov03-Mar04) Sub-Investigator
A Randomized, Double-Blind, Placebo-controlled Study Comparing the Analgesic Activity of (the study medicine) Extended Release and Placebo in Subjects with Pain Following Bunionectomy Surgery

SCIR0301 SCIREX 0005 (Sep03) Sub-Investigator
Clinical Protocol For A Multi-Center, Single Dose, Double-blind, Placebo-Controlled, Randomized, Pilot Study To Investigate the Assay Sensitivity of Single Digit Hammertoe Surgery As A Model For The Study Of Analgesic Drugs In Acute Pain.

*PHAR2719 (089) PARA-0505-089-P-1 (May03-Jul03) Principal Investigator
Revised Clinical Protocol for a Randomized Multiple Dose Assessment of the Safety of the (study med) Ready to Use (RTU) Formulation Compared to Parecoxib Sodium Lyophilized Preparation in Patients in Pain Following Bunionectomy

PHAR2564 PARA 0505 078 P (Oct02 - Feb 03) Sub-Investigator
Clinical Protocol for a Randomized, Double-Blind, Placebo Controlled, Multiple Dose Assessment of the Analgesic Efficacy of the Dosing Regimen of (study med name) Compared to Placebo Patients in Pain Following Bunionectomy

*PHAR 2563 PARA 0505 077 P (Oct 02 - Jan 03) Principal Investigator
Clinical Protocol for a Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of (study med name) Compared to Placebo in Patients for Treatment of Post-Surgical Pain from Bunionectomy Surgery

*KF0151Y/03 (01-02) Principal Investigator
A Randomized, Double-Blind, Parallel-Group Study Assessing the Analgesic Efficacy and Safety of Four Dose Levels of GRT0151Y (50 mg, 100 mg, 150 mg and 200 mg) compared to Ibuprofen 400 mg, Morphine 60 mg and Placebo in Patients with acute Pain Following Orthopedic Surgery (Bunionectomy).

Merck 052-00 (2001) Sub-Investigator
A randomized double-blind, Placebo and active comparator controlled parallel group multi-center study of study medication and naprelan in the treatment of post-bunionectomy surgery pain

*KF5503-05 (2001) Principal Investigator
A Randomized, Double-Blind, Parallel-Group, Dose-Ranging Study Assessing the Analgesic Efficacy and Safety of Five Dose Levels of CG5503 (25 mg, 50 mg, 75mg, 100 mg, and 200 mg) compared to Morphine 60mg, Ibuprofen 400 mg,and Placebo in patients following Orthopedic Surgery (Bunionectomy).

SKB 14777/277 (2000-2001) Sub-Investigator
Analgesic Efficacy of Single doses of Investigational Medication (900mg, 1350mg, 1800mg) and Multiple Doses of Investigational Medication (900mg UID or 450 mg BID) Compared with Single and Multiple doses of Naproxen Sodium 500mg or placebo in Patients with Pain from Outpatient Orthopedic surgery (Bunionectomy).

*SKB 14777/276 (2000) Principal Investigator
Comparative Analgesic Efficacy of Single and Multiple Doses of Investigational Medication (900mg, 1350mg, 1800mg), Naproxen Sodium 550mg or Placebo in Pain Following Outpatient Orthopedic surgery (Bunionectomy).

GD Searle & Co. N91-99-02-072 (1999-2000) Sub-Investigator
Clinical Protocol for A Double blind Placebo and Active-Controlled Comparison of the Analgesic Activity of Investigational Medication 40mg Oxycodone 10mg/acetaminophen 1000mg (Tylox) and Placebo in Post Bunionectomy Surgical Patients